arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Cardiff Lexington Corp

CDIX
— Price unavailable
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
77 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
75
Health
Good
Moderately Bullish
auto_awesome

Analytical Summary

Cardiff Lexington Corp demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap —
Dividend Yield —
Revenue Growth -22.6% ↗
Op. Margin -25.2% ↘
ROIC -1.8% ↗
FCF / Share $-0.04 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity 12.95
info Valuation on last close.

77-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.16M
↓ -22.6% —
Net Income Profit after all expenses
$-3.09M
↓ -585.9% —
Operating Margin Operating profit as % of sales
-25.2%
↓ -9.6% 55th
FCF / Share Free cash flow per share
$-0.04
↓ -3607.5% —
Long-Term Debt Long-term obligations
$22.73M
↑ +22.5% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
31
Returns ↑
100
Financial Health ↓
98

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 21 years · 77 quarters